Insulet Can't Keep Injunction During Trade Secret Appeal
The Federal Circuit has denied insulin product developer Insulet Corp.'s request to keep an injunction in place against rival EOFlow Co. Ltd. while it appeals an axed $59 million trade secrets...To view the full article, register now.
Already a subscriber? Click here to view full article